Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials (Q27852946)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials
scientific article

    Statements

    Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials (English)
    Christine Fritsch
    0 references
    Alan Huang
    0 references
    Christian Chatenay-Rivauday
    0 references
    Christian Schnell
    0 references
    Anupama Reddy
    0 references
    Manway Liu
    0 references
    Audrey Kauffmann
    0 references
    Daniel Guthy
    0 references
    Dirk Erdmann
    0 references
    Alain De Pover
    0 references
    Pascal Furet
    0 references
    Hui Gao
    0 references
    Stephane Ferretti
    0 references
    Youzhen Wang
    0 references
    Joerg Trappe
    0 references
    Saskia M Brachmann
    0 references
    Sauveur-Michel Maira
    0 references
    Christopher Wilson
    0 references
    Markus Boehm
    0 references
    Patrick Chene
    0 references
    Robert Cozens
    0 references
    Joseph Lehar
    0 references
    Robert Schlegel
    0 references
    Giorgio Caravatti
    0 references
    Francesco Hofmann
    0 references
    William R Sellers
    0 references
    May 2014
    0 references
    13
    0 references
    5
    0 references
    1117-29
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit